S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NASDAQ:NRXS

NeurAxis (NRXS) Stock Price, News & Analysis

$2.67
+0.12 (+4.71%)
(As of 12/29/2023 ET)
Today's Range
$2.36
$2.96
50-Day Range
$1.90
$3.27
52-Week Range
$1.80
$6.93
Volume
13,209 shs
Average Volume
14,668 shs
Market Capitalization
$14.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NRXS stock logo

About NeurAxis Stock (NASDAQ:NRXS)

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

NRXS Stock Price History

NRXS Stock News Headlines

NeurAxis (NASDAQ:NRXS) Trading Up 12%
New Year's Sale: Get 12 Months of Stock Picks for $9.00
Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this.
NeurAxis reports Q3 results
NeurAxis Reports Third Quarter 2023 Financial Results
NeurAxis Announces CareFirst BCBS Policy Coverage
New Year's Sale: Get 12 Months of Stock Picks for $9.00
Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this.
NeurAxis Secures $3 Million Financing
Neuraxis Inc NRXS Stock Quote
NeurAxis Reports Second Quarter 2023 Financial Results
NeurAxis Announces Over $8 Million in IB-Stim™ Revenue
NeurAxis Highlights Strength of its Board of Directors
See More Headlines
Receive NRXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/20/2023
Today
12/31/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NRXS
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.68 million

Miscellaneous

Free Float
N/A
Market Cap
$14.12 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Brian Carrico (Age 41)
    President, CEO & Director
    Comp: $373.58k
  • Dr. Adrian Miranda (Age 53)
    Chief Medical Officer, Senior VP of Science & Technology and Director
    Comp: $266.35k
  • Mr. Thomas Carrico (Age 66)
    Chief Regulatory Officer & Director
    Comp: $287.2k
  • Mr. Christopher Robin Brown D.D.S. (Age 69)
    Founder, Director of Innovation & Director
  • Mr. Gary Peterson (Age 57)
    Founder, Director of Design & Engineering and Director
  • Mr. John G. Seale CPA (Age 63)
    CFO & Teasurer
  • Mr. Dan Clarence (Age 63)
    COO & Director














NRXS Stock Analysis - Frequently Asked Questions

Should I buy or sell NeurAxis stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NeurAxis in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NRXS shares.
View NRXS analyst ratings
or view top-rated stocks.

How have NRXS shares performed in 2023?

NeurAxis' stock was trading at $6.00 at the beginning of 2023. Since then, NRXS shares have decreased by 55.5% and is now trading at $2.67.
View the best growth stocks for 2023 here
.

How were NeurAxis' earnings last quarter?

NeurAxis, Inc. (NASDAQ:NRXS) issued its earnings results on Monday, November, 20th. The company reported ($1.06) earnings per share for the quarter. The company earned $0.48 million during the quarter.

When did NeurAxis IPO?

(NRXS) raised $7 million in an IPO on Wednesday, August 9th 2023. The company issued 1,098,667 shares at $6.00 per share.

When does NeurAxis' lock-up period expire?

NeurAxis' lock-up period expires on Monday, February 5th. NeurAxis had issued 1,098,667 shares in its public offering on August 9th. The total size of the offering was $6,592,002 based on an initial share price of $6.00. After the end of NeurAxis' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

How do I buy shares of NeurAxis?

Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NRXS) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -